The scholarly study, ‘Physicians Slow to Implement HPV Vaccination and Cervical Screening Recommendations,’ was released July 9 in the American Journal of Preventive Medicine. ‘Screening for cervical cancers and additional cancers such as breast and prostate, has obvious potential for harms and also benefits, and these must be carefully weighed before a rational decision about screening could be made, ‘ wrote Harris and Sheridan, who are professor and assistant professor of medication, respectively, at UNC's School of Medication. They also hold adjunct appointments at UNC's Gillings School of Global Public Health. The study noted physicians said these were comfortable with longer testing intervals, but were worried their patients may not come in for annual check-ups if Pap tests, the screening check for cervical cancer, weren’t offered.Other awards consist of: Humanitarian PA of the entire year, Outstanding PA of the Year, PA Services to the Underserved Award, and the Physician-PA Partnership Award.
2010 promises to keep acquisition activity as companies seek methods to bolster their pipelines and portfolios According to pharmaceutical deal makers, the recent round of industry M&A is far from over. Previously year, drug makers’ thirst for innovation combined with small businesses’ dwindling working capital to drive merger and acquisition activity.